Home
|
Inbox
|
Search
|
Speaker
Alejhandra Lei
MD
AstraZeneca
Session(s)
- A Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial of AZD8871, a Novel Dual-Act...
Monday, May 21 9:15 AM - 9:30 AM - All-Cause Mortality in COPD Patients Treated with Aclidinium and Other Inhaled Bronchodila...
Monday, May 21 2:15 PM - 4:15 PM - An Ascending, Repeat-Dose Safety and Tolerability Study of AZD8871 a Novel, Dual-Acting Br...
Tuesday, May 22 11:15 AM - 1:00 PM
|
Home
|
Inbox
|
Search
|